These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29374971)

  • 1. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
    Yan HM; Sun E; Cui L; Jia XB; Jin X
    J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
    Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM
    BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
    Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
    Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic.
    Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A
    Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
    Biswas N
    Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanorods for improved oral drug absorption.
    Zheng N; Li J; Xu C; Xu L; Li S; Xu L
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1132-1140. PubMed ID: 28783976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V; Lin SX; Lee CH; Weng CF
    Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
    Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
    Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, Characterization, and Evaluation of Mesoporous Silica Nanoparticles in Enhancing Oral Bioavailability of Poorly Water-Soluble Drugs.
    Zhang H; Zuo F; Wang B; Qiu X
    Curr Drug Deliv; 2024; 21(11):1529-1536. PubMed ID: 38310438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
    Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
    Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
    Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
    Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
    Roggers RA; Lin VS; Trewyn BG
    Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.